April 09, 2020
Lupin Pharmaceuticals Inc. is recalling a single lot of lisinopril tablets after a customer discovered a 5-mg tablet in a bottle that was supposed to contain 30-mg tablets, according to the April 8, 2020, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects 100-count bottles of lisinopril tablets, 30 mg (NDC 68180-982-01), from lot Q900580 (Exp. 9/21). More than 25,000 bottles from the lot were distributed throughout the United States.
Lupin Pharmaceuticals voluntarily initiated the recall April 1, 2020. The FDA designated the recall Class II on April 2, 2020, communicating use of the drug may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Lisinopril is a prescription ACE inhibitor used to treat high blood pressure, congestive heart failure, or to improve survival after a heart attack.